Pfizer CEO Discusses New Administration with CNBC

(8:5)

Science Will Win Season 1 - BONUS EPISODE - Into the Pfizer Lab Making a Gene Therapy

(14:51)

Science Will Win Season 1 - What’s Next For Gene Therapy?

(31:5)

Science Will Win Season 1 - The Policy Puzzle

(28:57)

Science Will Win Season 1 - Clinical Trials Courage and Perseverance

(26:39)

Science Will Win Season 1 - Gene Therapy – Behind the Science

(25:29)

Science Will Win Season 1 Trailer

(8:58)

Science Will Win Season 2 - Part 2 - Clinical Trials: Bringing Research to Life

(29:24)

Science Will Win Season 2 - Part 1 - Breast Cancer: The Science, The Challenges, The Solutions

(30:58)

Science Will WIn Season 2 Trailer

(9:18)

Pfizer Commercial – Here’s to Science – Extended Cut

(1:31)

Day in the Life: Pfizer Scientist

(51)

Pfizer CEO: Americans can expect radical change from this upcoming Trump administration

(4:14)

Mission Possible: The Race for a Vaccine

(44:13)

'Fast Money' traders talk Trump calling for lower interest rates

(5:25)

Scale AI CEO Alexandr Wang on U.S.-China AI race: We need to unleash U.S. energy to enable AI boom

(7:50)

Jim Cramer talks how to navigate President Trump's rhetoric

(11:13)

Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon

(1:1:48)

SMBC's Joe Lavorgna on Trump's call for lower interest rates

(5:56)

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial

(6:24)

The COVID Clots: A Full Measure Town Hall

(51:9)

FACT CHECK: Pfizer CEO Says Company Aims to Reduce World Population by Half by 2023?

(1:54)

Pfizer Big Game Commercial 2024 – Here’s to Science

(1:1econd)

Pfizer vaccine risk detected, CDC says

(35)

Pfizer's DNA

(1:25)

Science confirms SV40 DNA in Pfizer’s COVID shot, validating concerns over genetic health risks

(15:41)

Pfizer battles activist fund Starboard, which has a $1 billion stake in company

(1:39)

Kansas sues Pfizer over COVID-19 vaccine

(1:55)

Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline

(5:51)

Pfizer is 'deeply sorry'

(13:46)

Pfizer climbs 4% on 2025 outlook

(3:27)

Moderna v Pfizer, deaths

(24:43)

Activist Investor Starboard Value Take $1 Billion Stake in Pfizer

(1:17)

Pfizer CEO: Cancer drugs will be our next big contribution to the world

(3:44)

Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030

(4:30)

Science Will Win 2022

(1:1econd)

Happy 175 Years Pfizer!

(1:40)